Patients’ mean pain levels fell from 6.16 prior to cannabis treatment to 3.89 following treatment.
Topic: Health/Safety
Nearly 1 in 4 pain patients residing in states where medical cannabis access is legal identify as marijuana consumers.
“Cannabis and CBD were found to be most effective in managing chronic secondary musculoskeletal pain, chronic secondary visceral pain and chronic neuropathic pain,” investigators concluded.
“Cannabis-based products for medicinal use … can improve musculoskeletal, somatic, and psychiatric symptoms in patients with fibromyalgia,” the study’s authors determined.
“Among participants with anxiety and/or depression and pre-existing sleep problems at baseline, using cannabis … was associated with fewer sleep problems at follow-up,” researchers reported.
“This study shows that treatment with CBD-rich oil is effective and safe for patients with neuropsychiatric symptoms secondary to Alzheimers.”
Investigators found “no statistically significant associations between a history of regular cannabis smoking … and the prevalence of carotid calcified plaque.”
Pain patients also experienced “a notable decline in their use of both prescription and over-the-counter pain medications” following their use of medical cannabis.